Clover Corporation (ASX: CLV) — Perfil da empresa, notícias e dados financeiros
Clover Corporation is an Australian company specializing in the refining, encapsulation, and delivery of bioactive functional ingredients for the global nutrition, healthcare, and infant food sectors.
Clover Corporation
Clover Corporation is an Australian company specializing in the refining, encapsulation, and delivery of bioactive functional ingredients for the global nutrition, healthcare, and infant food sectors. Operating primarily through its subsidiary Nu-Mega Ingredients, the company refines tuna and algal oils rich in docosahexaenoic acid (DHA) and omega-3 fatty acids using patented microencapsulation technologies. Its encapsulated powders and oil formulations protect sensitive bioactive nutrients from oxidation and off-flavors, enabling seamless integration into infant formula, pediatric nutrition, dietary supplements, and medical foods. Clover Corporation distributes its specialized nutrient solutions to food and pharmaceutical manufacturers across Australasia, Asia, Europe, and North America.
Resumo
Operações
Produtos e/ou serviços de Clover Corporation
- Microencapsulated DHA Powders: Delivery of spray-dried microencapsulated tuna and algal oil powders designed for infant formula and pediatric nutrition products, providing oxidative stability and masking unpleasant marine tastes during long-term shelf storage.
- High-DHA Tuna and Algal Oils: Processing and bulk supply of refined tuna and algae-derived polyunsaturated fatty acid oils high in docosahexaenoic acid for incorporation into liquid medical foods, dietary supplements, and functional food products globally.
- Pediatric and Clinical Lipid Formulations: Production of specialized lipid formulations tailored to deliver essential fatty acids to premature infants and specialized pediatric clinical applications, supporting physiological and neurodevelopmental growth in clinical healthcare settings.
- Microencapsulation Technology Licensing and R&D: Development and licensing of proprietary spray-drying and matrix microencapsulation processing methods to encapsulate sensitive bioactive lipids, vitamins, and minerals for commercial food processing and pharmaceutical manufacturers.
- Nutraceutical and Functional Food Ingredients: Supply of customizable omega-3, omega-6, and bioactive nutrient blends formatted for adult nutritional drinks, dairy products, bakery goods, and health supplements across global consumer healthcare markets.
- Manufacturing Facility Operations: Operation of spray-drying, processing, and quality control facilities in Victoria and Queensland, Australia, providing commercial-scale lipid extraction, microencapsulation, packaging, and global export infrastructure to international regulatory standards.
equipe executiva do Clover Corporation
- Peter J. DaveyCEO, MD & Executive Director
- Andrew G. M. AllibonCFO & Company Secretary
- David PierottiDirector of Operations
- Bassam HallakDirector of Sales & Marketing
- Anne RoachGeneral Manager of People & Culture
Últimas notícias sobre a Clover Corporation
Comunicados recentes
O que a Clover Corporation (CLV) comunicou ao mercado, do mais recente para o mais antigo.
- Substantial Shareholder Notice
- Change of KMP Interest - Appendix 3Y
- Change of KMP Interest - Appendix 3Y
- Change of Director's Interest Notice
- Change of Director's Interest Notice
- Change in substantial holding from PPT
- Non Executive Director Appointment
Histórico de dividendos
Dividendos por ação pagos pela Clover Corporation, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2027(até o momento) | A$0.0125 | — | — | A$0.0125 |
| FY2026 | A$0.0100 | — | — | A$0.0200 |
| FY2025 | A$0.0075 | A$0.0075 | — | A$0.0150 |
| FY2024 | A$0.0075 | — | — | A$0.0075 |
| FY2023 | A$0.0100 | A$0.0075 | — | A$0.0175 |
Principais indicadores financeiros
Resultados divulgados pela Clover Corporation, em AUD.
- Cap. de mercado
- 166,2 mi
- Receita (TTM)
- 97,4 mi
- P/L
- 16.6
- LPA (diluído, TTM)
- 0.1
- Dividend yield
- 2.3%
- Margem de lucro
- 10.7%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 97,4 mi | 16,3 mi | 10,5 mi | |
| 86 mi | 8,3 mi | 7 mi | |
| 62,2 mi | 3,1 mi | 1,5 mi | |
| 79,9 mi | 10 mi | 6,2 mi |